• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Section Contents Menu

  • Enforcement Actions
  • -

    Paul Ramer Construction 17-Dec-02

    Department of Health and Human ServicesDepartment of Health and Human Services            Public Health Service


    CERTIFIED MAIL
    RETURN RECEIPT REQUESTED

    Food and Drug Administration
    Detroit District
    300 River Place
    Suite 5900
    Detroit, MI 48207
    Telephone: 313-393-8100
    FAX: 313-393-9139

    WARNING LETTER
    2003-DT-06
    December 17, 2002

    Mr. Paul Ramer, Owner
    Paul Ramer Construction
    8287 East 128 Road
    Argos, Indiana 46501

    Dear Mr. Ramer:

    During an investigation of your dairy farm located at 8287 East 12B Road, Argos, Indiana 46501, on March 21-22,2002 a Food and Drug Administration (FDA) investigator found that you caused the adulteration of a new animal drug within the meaning of Section 501(a)(5) of the Federal Food, Drug, and Cosmetic Act (The Act) and of a medicated animal feed within the meaning of section 501(a)(6) of the Act.

    From approximately June 17, 1999 through March 12, 2002, you continuously fed [redacted] medicated feed containing the new animal drug [redacted] to your lactating dairy cows. [redacted] has not been approved for use in lactating dairy cows as provided in 21 CFR 558.95. By feeding the [redacted] medicated feed to your lactating dairy cows, you used [redacted] in a manner that does not conform with an approved new animal drug application as required by section 512(a)(1) of the Act. For this reason the drug is unsafe under section 512 of the Act and thus adulterated under section 501 (a)(5) of the Act. The medicated feed you fed to your lactating dairy cows is unsafe under section 512(a)(2) of the Act because it bears or contains a new animal drug that does not conform with an approved application. The feed is thus adulterated under section 501 (a)(6) of the Act.

    During the inspection you told the FDA investigator that the milk from cows that were fed the [redacted] medicated feed was sold to [redacted] for human food. You should ensure that you have an adequate system for assuring that your dairy cows are treated only with drugs that are approved for use in lactating dairy cows. In addition, you should assure that animals and animal-derived food products, such as milk, have been withheld from slaughter and/or shipment for appropriate periods of time to permit depletion of potentially hazardous residues of drugs from edible tissues.

    The above is not intended as an all-inclusive list of violations. As a producer of animals and animal products offered for use as food, you are responsible for assuring that your overall operation and the foods you distribute are in compliance with the law. You should take prompt action to correct these violations, and you should establish procedures whereby such violations do not recur. Failure to promptly correct these violations may result in regulatory action without further notice, such as seizure and/or injunction. This letter notifies you of our findings and provides you an opportunity to correct the above deficiencies.

    You should notify this office, in writing, within fifteen (15) working days of the receipt of this letter of the steps you have taken to bring your firm into compliance with the law.

    Your response should include an explanation of each step being taken to correct the violations and prevent their recurrence. If corrective action cannot be completed within 30 working days, state the reason for the delay and the date by which the corrections will be completed. Include copies of any available documentation demonstrating that corrections have been made.

    Your response should be directed to Mr. David M. Kaszubski, Director Compliance Branch, at the above address.

    Sincerely yours,

    /s/

    John P. Dempster for Joann M. Givens

    District Director

    Detroit District Office

     

    -
    -